MEDVET is a consultancy in Antwerpen. Private Limited, started on 27 November 1992, 1 establishment.

What is the address of MEDVET?

The registered office of MEDVET is located at Emiel Vloorsstraat 9, 2020 Antwerpen.

Is MEDVET still active?

Yes. According to the CBE (31 October 2026) MEDVET is active, legal situation “Normale toestand”, started on 27 November 1992.

Is MEDVET registered on Peppol?

Yes, MEDVET is registered on the Peppol network with ID 0208:0448758523.

What is the enterprise number of MEDVET?

The enterprise number of MEDVET is BE0448758523.

When was MEDVET founded?

MEDVET was founded on 27 November 1992.

Who are the directors of MEDVET?

According to the 2025 annual accounts, the directors of MEDVET are: Ascolabo.

Is MEDVET a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 November 1992; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDVET make in 2025?

MEDVET posted a profit after taxes of € 2,838,437 in financial year 2025.

What is the revenue of MEDVET?

In its most recent annual accounts (2025), MEDVET reported revenue of € 7,684,064.

How much does an employee at MEDVET earn?

The average wage cost per full-time employee at MEDVET was € 148,800 in 2025: staff costs of € 1.9 million for 12.9 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does MEDVET have?

According to the 2025 annual accounts, MEDVET has 12.9 full-time equivalents (FTE).

MEDVET (Private Limited) - Antwerpen - BE0448758523

Dossier MEDVET, printed on 31 October 2026 from databakkes.be/en/0448758523/medvet. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDVET from Antwerpen, company number BE0448758523, closed financial year 2025 with a result of € 2.8 million after tax. For that financial year MEDVET recorded revenue of € 7.7 million and equity of € 3.1 million. Compared with financial year 2024, the result moved from € 2.6 million to € 2.8 million. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 13, 2026.

What it is worth Growing

€ 3.1 million

▲ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 2.8 million

▲ 11% vs 2024

Profit after tax over the fiscal year.

Where the profit goes Pays out

€ 2.5 million paid out

88 % of the profit went to the shareholders, mostly to A.M.L. (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

12.9

▼ 0.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 5.4 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 1.9 million

▼ 6% vs 2024

€ 148,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 84,479

▼ 15% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2.1 million

▲ 68% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 128 days on average.

Taxes and wages

€ 1.2 million

▲ 38% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 6,526,047 Revenue 2022: € 6,526,047 First fiscal year in the series	€ 6,652,347 Revenue 2023: € 6,652,347 ▲ 2% vs 2022 (€ 6,526,047) Favourable step	€ 7,170,970 Revenue 2024: € 7,170,970 ▲ 8% vs 2023 (€ 6,652,347) Favourable step	€ 7,684,064 Revenue 2025: € 7,684,064 ▲ 7% vs 2024 (€ 7,170,970) Favourable step	▲ 7%
Profit after taxes	€ 2,217,957 Profit after taxes 2022: € 2,217,957 First fiscal year in the series	€ 2,324,205 Profit after taxes 2023: € 2,324,205 ▲ 5% vs 2022 (€ 2,217,957) Favourable step	€ 2,559,030 Profit after taxes 2024: € 2,559,030 ▲ 10% vs 2023 (€ 2,324,205) Favourable step	€ 2,838,437 Profit after taxes 2025: € 2,838,437 ▲ 11% vs 2024 (€ 2,559,030) Favourable step	▲ 11%
Equity	€ 2,408,990 Equity 2022: € 2,408,990 First fiscal year in the series	€ 2,233,195 Equity 2023: € 2,233,195 ▼ 7% vs 2022 (€ 2,408,990) Unfavourable step	€ 2,792,225 Equity 2024: € 2,792,225 ▲ 25% vs 2023 (€ 2,233,195) Favourable step	€ 3,130,661 Equity 2025: € 3,130,661 ▲ 12% vs 2024 (€ 2,792,225) Favourable step	▲ 12%
Total debts	€ 4,950,926 Total debts 2022: € 4,950,926 First fiscal year in the series	€ 4,718,835 Total debts 2023: € 4,718,835 ▼ 5% vs 2022 (€ 4,950,926) Favourable step	€ 4,164,089 Total debts 2024: € 4,164,089 ▼ 12% vs 2023 (€ 4,718,835) Favourable step	€ 5,857,274 Total debts 2025: € 5,857,274 ▲ 41% vs 2024 (€ 4,164,089) Unfavourable step	▲ 41%
Land & buildings	€ 4,983 Land & buildings 2022: € 4,983 First fiscal year in the series	€ 2,920 Land & buildings 2023: € 2,920 ▼ 41% vs 2022 (€ 4,983) Unchanged	€ 2,061 Land & buildings 2024: € 2,061 ▼ 29% vs 2023 (€ 2,920) Unchanged	€ 1,473 Land & buildings 2025: € 1,473 ▼ 29% vs 2024 (€ 2,061) Unchanged	▼ 29%
Retained profit	€ 2,390,390 Retained profit 2022: € 2,390,390 First fiscal year in the series	€ 2,214,595 Retained profit 2023: € 2,214,595 ▼ 7% vs 2022 (€ 2,390,390) Unfavourable step	€ 2,773,625 Retained profit 2024: € 2,773,625 ▲ 25% vs 2023 (€ 2,214,595) Favourable step	€ 3,112,061 Retained profit 2025: € 3,112,061 ▲ 12% vs 2024 (€ 2,773,625) Favourable step	▲ 12%
Dividend	€ 3,000,000 Dividend 2022: € 3,000,000 First fiscal year in the series	€ 2,500,000 Dividend 2023: € 2,500,000 ▼ 17% vs 2022 (€ 3,000,000) Unchanged	€ 2,000,000 Dividend 2024: € 2,000,000 ▼ 20% vs 2023 (€ 2,500,000) Unchanged	€ 2,500,000 Dividend 2025: € 2,500,000 ▲ 25% vs 2024 (€ 2,000,000) Unchanged	▲ 25%
Balance sheet total	€ 7,359,916 Balance sheet total 2022: € 7,359,916 First fiscal year in the series	€ 6,952,030 Balance sheet total 2023: € 6,952,030 ▼ 6% vs 2022 (€ 7,359,916) Unchanged	€ 6,956,314 Balance sheet total 2024: € 6,956,314 Unchanged (€ 6,952,030) Unchanged	€ 8,987,935 Balance sheet total 2025: € 8,987,935 ▲ 29% vs 2024 (€ 6,956,314) Unchanged	▲ 29%
Employees (FTE)	15.3 Employees (FTE) 2022: 15.3 First fiscal year in the series	13.5 Employees (FTE) 2023: 13.5 ▼ 1.8 vs 2022 (15.3) Unchanged	13.5 Employees (FTE) 2024: 13.5 Unchanged (13.5) Unchanged	12.9 Employees (FTE) 2025: 12.9 ▼ 0.6 vs 2024 (13.5) Unchanged	▼ 0.6

Key figures of MEDVET, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDVET?

What happened at MEDVET in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 13, 2026 New annual accounts for financial year 2025: profit of € 2.8 million (▲ 11% vs 2024). Source: NBB ↗
2024 Ascolabo became a director. NBB
Dec 18, 1992 New establishment in Antwerpen. KBO
Nov 27, 1992 Start of the company according to the CBE. KBO

In short

From € 2.2 million profit in 2022 to € 2.8 million profit in 2025.

Paid € 3.4 million in corporate taxes since 2022.

Best year ever: 2025, with € 2.8 million profit.

Paid out € 10 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

A.M.L. 100%

The stake of A.M.L. comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

MEDVET

Behind MEDVET is Ascolabo. The shares are held by A.M.L. (100%).

Directors

According to the 2025 annual accounts

Ascolabo

Director · represented by Astrid Coppens

since 2024

Shareholders

A.M.L.

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Emiel Vloorsstraat 9

2020 Antwerpen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

A.M.L. same network

€ 54.2 million revenue · 2025

SONIC HEALTHCARE BENELUX

€ 540,919 revenue · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0448.758.523

VAT number

BE 0448.758.523

Registered office

Emiel Vloorsstraat 9, 2020 Antwerpen

Names & denominations

MEDVET

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

27 November 1992

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Activiteiten van medische beeldvorming en medische laboratoria

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Activiteiten van medische laboratoria

Medische laboratoria

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDVET

Financials

What happened to MEDVET?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions